Steris (STE) reported $1.28 billion in revenue for the quarter ended June 2024, representing a year-over-year decline of 0.4%. EPS of $2.03 for the same period compares to $2.00 a year ago. The reported revenue represents a surprise of +1.47% over the Zacks Consensus Estimate of $1.26 billion. With the consensus EPS estimate being $2.01, the EPS surprise was +1.00%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expecta ...

Steris (STE) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 1%. A quarter ago, it was expected that this medical products maker would post earnings of $2.41 per share when it actually produced earnings of $2.41, delivering no surprise. Over the last four quarters, the company has surpas ...

财务业绩 - 总收入同比增长8%，以恒定汇率计算的有机收入增长6%[2] - 报告期内每股收益为1.41美元，调整后每股收益为2.03美元[4] - 公司维持了2025财年的业绩指引[3] - 公司预计2025财年收入将增长6.5-7.5%,以恒定汇率计算的有机收入增长6-7%,调整后每股收益将在9.05-9.25美元之间[9] - 公司2024年第二季度总收入为12.795亿美元，同比增长8.1%[21] - 公司2024年第二季度毛利润为5.724亿美元，同比增长8.2%[21] - 公司2024年第二季度经营利润为1.855亿美元，同比下降6.2%[21] - 公司2024年第二季度持续经营净利润为1.399亿美元，同比增长7.2%[21] - 公司2024年第二季度每股收益(EPS)为1.46美元，同比增长16.8%[21] - 公司总收入为11.83亿美元，其中经常性收入为9.13亿美元，占总收入的77%[43] - 公司预计2025财年每股调整后净收益为9.05-9.25美元[40] - 公司预计2025财年经营活动产生的现金流为10.6亿美元，资本支出为3.6亿美元，自由现金流为7亿美元[41] 业务表现 - 医疗保健业务收入增长10%，其中耗材收入增长23%，服务收入增长14%，但资本设备收入下降10%[5] - 应用灭菌技术业务收入增长7%，其中服务收入增长7%，资本设备收入增长24%[6] - 生命科学业务收入下降2%，主要由于CECS业务剥离,但耗材收入增长13%[7] - 公司2024年第二季度Healthcare业务收入为9.012亿美元，同比增长10.1%[34] - 公司2024年第二季度AST业务收入为2.498亿美元，同比增长7.2%[34] - 公司2024年第二季度Life Sciences业务收入为1.285亿美元，同比下降2.2%[34] - 医疗保健业务收入为9.01亿美元，占总收入的76%，分部利润为2.17亿美元[43] - 生命科学业务收入为1.28亿美元，分部利润为5258万美元[43] - 公司2025财年第一季度医疗保健业务订单回升至3.62亿美元，生命科学业务订单回升至7220万美元[43] 市场表现 - 美国市场收入占总收入的74%，爱尔兰市场收入占2%，国际市场收入占24%[43] - 公司2025财年第一季度美国市场收入占比74%，较上年同期上升2个百分点[43] - 公司2025财年第一季度国际市场收入占比24%，较上年同期下降2个百分点[43] 其他 - 公司2024年第二季度自由现金流为1.957亿美元[31] - 公司2024年第二季度以不变汇率计算的有机收入增长为5.6%[34] - 公司2025财年第一季度调整后税率为21.3%，较上年同期下降1个百分点[43]

Total revenue from continuing operations increased 8%; constant currency organic revenue grew 6% As reported EPS from continuing operations increased to $1.41; adjusted EPS increased to $2.03 Fiscal 2025 outlook reiterated DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1. ...

Total revenue from continuing operations increased 8%; constant currency organic revenue grew 6% As reported EPS from continuing operations increased to $1.41; adjusted EPS increased to $2.03 Fiscal 2025 outlook reiterated DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1. ...

In its upcoming report, Steris (STE) is predicted by Wall Street analysts to post quarterly earnings of $2.03 per share, reflecting an increase of 1.5% compared to the same period last year. Revenues are forecasted to be $1.26 billion, representing a year-over-year decrease of 1.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Ahead of a c ...

DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company's 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024. Additional information about the U.S. tax treatment of dividends, including require ...

DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company's 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024. Additional information about the U.S. tax treatment of dividends, including require ...

DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will be ...

DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will be ...